Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc.

District Court, S.D. New York·Decided June 20, 2025·No. 1:24-cv-01810·Unknown

Opinion

USDC SDNY DOCUMENT UNITED STATES DISTRICT COURT ELECTRONICALLY FILED SOUTHERN DISTRICT OF NEW YORK DOC #: monn nrc nanan KK DATE FILED:_ 6/20/2025 RECOOP LLC, : Plaintiff, : : 24-cv-01810 (LJL) -v- : : MEMORANDUM & OUTLIERS INC. d/b/a THESIS : ORDER NOOTROPICS INC., : Defendant. :

OUTLIERS INC. d/b/a THESIS : NOOTROPICS INC. and DANIEL : FREED, : Counterclaim and : Third-party Plaintiffs. : -v- : RECOOP LLC and ANASTASIA ALT, : Counterclaim and : Third-party Defendants. : wee KX LEWIS J. LIMAN, United States District Judge: Plaintiff Recoop LLC (“Plaintiff’ or “Recoop”) moves for reconsideration, pursuant to Local Rule 6.3, of this Court’s Opinion and Order of April 14, 2025, granting summary judgment for Defendant Outliers Inc. d/b/a Thesis Nootropics Inc. (“Defendant” or “Thesis”). Thesis moves, pursuant to Federal Rule of Civil Procedure 11 and the Defend Trade Secrets Act (“DTSA”), 18 U.S.C. § 1836(b)(3)(D), for an award of attorney’s fees. Dkt. No. 102. For the reasons that follow, Recoop’s motion for reconsideration is denied, Thesis’s motion for Rule 11 sanctions and for attorney’s fees under the DTSA is denied.

BACKGROUND I. Procedural History This case has, from the outset, been riddled with accusations from Plaintiff which have not been followed by proof or even efforts to obtain proof. An extended discussion of the procedural history is necessary for an explanation of the Court’s decision on this motion. Plaintiff describes itself as a “direct-to-consumer startup that sells nutritional supplements

for people who take stimulants for focus and concentration.” Dkt. No. 1 ¶ 6. It describes Thesis as a competitor and “a high-flying direct-to-consumer startup company in the buzzy ‘nootropic’ health supplement space.” Id. ¶ 1. Plaintiff began this case on March 8, 2024, accusing Defendant of stealing its trade secrets in violation of the DTSA and the common law, as well as the Wiretap Act, 18 U.S.C. § 2510, et seq., and the California Invasion of Privacy Act (“CIPA”), Cal. Pen. Code §§ 630–638. Dkt. No. 1. It alleged that “Thesis—then reportedly operating out of its founder’s apartment during its ‘humble beginnings’—gained access to Recoop’s website backend and secretly inserted two tracking devices in the form of computer code—a Meta Facebook & Instagram

Pixel and a Google Site Tag” and used those two components to obtain customer communications and proprietary data, to build its own business, and to “sabotage Recoop’s digital advertising and marketing efforts that were deployed using Recoop’s own (legitimate) Meta Facebook & Instagram Pixel and Google Site Tag.” Id. ¶¶ 7–9. Recoop failed to disclose that the Thesis “founder” in question was an individual named Daniel Freed (Counterclaim- Plaintiff, hereafter “Freed”), who was also an employee of Recoop at the time of the alleged access and installation. It was in Freed’s capacity as a Recoop employee and with Recoop’s permission that he gained access to Recoop’s website backend, and it was for Recoop’s benefit and with its knowledge that he inserted the computer code. Thesis answered the original complaint and filed counterclaims against Recoop on May 24, 2024, Dkt. No. 13, including third-party claims by Freed against Recoop and its founder and Chief Executive Officer Anastasia Alt (“Alt”). Id. Thesis and Freed amended their answer and counterclaims in response to Recoop’s First Amended Complaint on July 3, 2024, Dkt. No. 23.1

Thesis and Freed counterclaim that Freed was a co-founder, member, officer, and employee of Recoop during the time relevant to Recoop’s complaint, and that he worked on Recoop’s website and inserted marketing pixels and tags under the direction of and with the knowledge of Alt. Id. ¶ 71. They deny that Freed or Thesis improperly accessed or used Recoop’s confidential information after his departure from Recoop. Id. ¶¶ 34–39. Thesis and Freed asserted counterclaims and third-party claims against Recoop and Alt for a declaratory judgment that no breach of Freed’s separation agreement had occurred, defamation, breach of contract, and tortious interference with prospective business relations. Id. ¶ 9. Recoop, then represented by Ariel Reinitz, Esq., submitted a proposed Case Management Plan and Scheduling Order on July 8, 2024. Dkt. No. 24. The proposed Case Management Plan

and Scheduling Order provided for initial requests for production of documents and interrogatories to be served by August 5, 2024, depositions to be completed by November 12, 2024, all fact discovery to be completed by November 12, 2024, and expert discovery to be completed by December 27, 2024. Id. The Court adopted the Case Management Plan and

1 Plaintiff filed its First Amended Complaint (“FAC”) against Thesis on June 28, 2024. Dkt. No. 19. The FAC contained substantially identical allegations, merely adding “Google Analytics Pixel” to “Meta Facebook & Instagram Pixel and a Google Site Tag” as a technology Plaintiff alleges Thesis used to spy on Recoop’s website activity, and in some places, using more passive language to characterize Thesis’s alleged misconduct, compare Dkt. No. 1 ¶ 35 (“Thesis— through its CEO, Dan Freed . . . installed,”) with Dkt. No. 19 ¶ 36 (“Thesis—through its CEO, Dan Freed . . . caused . . . to be installed”). Scheduling Order as proposed on July 15, 2024. Dkt. No. 26. The parties later agreed on a protective order and an ESI protocol. Dkt. Nos. 30–31, 34–35. On August 2, 2024, the Court granted Thesis and Freed’s letter motion for an expedited forensic examination by Stroz Friedberg LLC (“Stroz Friedberg”) on the question whether

Free access — add to your briefcase to read the full text and ask questions with AI

Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc., (S.D.N.Y. 2025).

Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc. (Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Fogerty v. Fantasy, Inc.
510 U.S. 517 (Supreme Court, 1994)
Dyer v. MacDougall
201 F.2d 265 (Second Circuit, 1952)
Trans Sport, Inc. v. Starter Sportswear, Inc.
964 F.2d 186 (Second Circuit, 1992)
Bruce C. Shrader v. Csx Transportation, Inc.
70 F.3d 255 (Second Circuit, 1995)
Fujitsu Limited v. Federal Express Corporation
247 F.3d 423 (Second Circuit, 2001)
Pepsico, Inc. v. The Coca-Cola Company
315 F.3d 101 (Second Circuit, 2002)
Analytical Surveys, Inc. v. Tonga Partners, L.P.
684 F.3d 36 (Second Circuit, 2012)
Selevan v. New York Thruway Authority (NYTA)
711 F.3d 253 (Second Circuit, 2013)
Cordiano v. Metacon Gun Club, Inc.
575 F.3d 199 (Second Circuit, 2009)
Tullidge v. Board of Supervisors
391 S.E.2d 288 (Supreme Court of Virginia, 1990)
De Luca v. Atlantic Refining Co.
176 F.2d 421 (Second Circuit, 1949)